Answer
Elvanse (lisdexamfetamine dimesylate) is indicated as part of a comprehensive ADHD treatment programme for children aged 6 years and over whose response to previous methylphenidate treatment is considered clinically inadequate, under specialist supervision.
Sources for this answer
- Elvanse 20mg Hard CapsulesTakeda UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked